• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用模块化生物库软件开展不同类型的生物库活动。

Utilizing Modular Biobanking Software in Different Types of Biobanking Activities.

机构信息

Modul-Bio, Marseille, France.

出版信息

Biopreserv Biobank. 2022 Oct;20(5):417-422. doi: 10.1089/bio.2022.0076. Epub 2022 Oct 5.

DOI:10.1089/bio.2022.0076
PMID:36201224
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9603250/
Abstract

Biobanking defines all activities linked to bioresource management-whether of human, animal, microbial, or environmental origin-which means that any biobank information management system should take into account the multistep life cycle of the samples: from acquisition, through preparation, storage, to distribution to the end users (medical or research teams). Different types of biobanks can use diverse approaches, making it difficult to find software that can handle all types of scenarios. Modul-Bio has developed MBioLIMS BioBanking, a software dedicated to biobanking, as a modular solution so that our various clients can access the functionalities and scale in a system to match their needs. These projects range from biobanks setup and managed by academic institutions, hospitals, and private companies to small and large clinical trials across different countries, as well as to whole campus or organization solutions for multiple biorepositories. Each solution differs in size, requirements, and number of users, from small biobanks with a few members of staff accessing the software to large operations with multiple sites that can collect and ship samples to a centralized site. This article explores different projects that use Modul-Bio's software in a myriad of ways to manage the complete life cycle of biospecimens and associated data.

摘要

生物库定义了所有与生物资源管理相关的活动——无论是人类、动物、微生物还是环境来源,这意味着任何生物库信息管理系统都应考虑样本的多步骤生命周期:从采集,到准备、存储,再到分发给最终用户(医疗或研究团队)。不同类型的生物库可以使用不同的方法,因此很难找到能够处理所有类型场景的软件。Modul-Bio 开发了 MBioLIMS BioBanking,这是一款专门用于生物库的软件,作为一个模块化解决方案,以便我们的各种客户可以在一个系统中访问功能和规模,以满足他们的需求。这些项目涵盖了由学术机构、医院和私营公司管理的生物库,以及跨越不同国家的小型和大型临床试验,以及针对多个生物库的整个校园或组织解决方案。每个解决方案在规模、要求和用户数量上都有所不同,从小型生物库只有少数员工访问软件,到大型运营,多个站点可以收集和运送样本到集中站点。本文探讨了不同的项目,这些项目以多种方式使用 Modul-Bio 的软件来管理生物样本和相关数据的完整生命周期。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e4d/9603250/bb739b40143f/bio.2022.0076_figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e4d/9603250/bb739b40143f/bio.2022.0076_figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e4d/9603250/bb739b40143f/bio.2022.0076_figure1.jpg

相似文献

1
Utilizing Modular Biobanking Software in Different Types of Biobanking Activities.利用模块化生物库软件开展不同类型的生物库活动。
Biopreserv Biobank. 2022 Oct;20(5):417-422. doi: 10.1089/bio.2022.0076. Epub 2022 Oct 5.
2
The Future of Biobanking: A Conceptual Look at How Biobanks Can Respond to the Growing Human Biospecimen Needs of Researchers.生物样本库的未来:关于生物样本库如何应对研究人员对人类生物样本日益增长的需求的概念性探讨。
Adv Exp Med Biol. 2015;864:11-27. doi: 10.1007/978-3-319-20579-3_2.
3
An Introduction to Hardware, Software, and Other Information Technology Needs of Biomedical Biobanks.生物医学样本库的硬件、软件及其他信息技术需求介绍
Methods Mol Biol. 2019;1897:17-29. doi: 10.1007/978-1-4939-8935-5_3.
4
ISO 20387 biobanking standard. Analysis of requirements and experience of implementation.ISO 20387 生物库标准。需求分析与实施经验。
Klin Lab Diagn. 2020 Sep 16;65(9):587-592. doi: 10.18821/0869-2084-2020-65-9-587-592.
5
National Association of Biobanks and Biobanking Specialists: New Community for Promoting Biobanking Ideas and Projects in Russia.全国生物银行和生物银行专家协会:在俄罗斯促进生物银行理念和项目的新社区。
Biopreserv Biobank. 2021 Feb;19(1):73-82. doi: 10.1089/bio.2020.0049. Epub 2020 Oct 15.
6
The landscape of biobanks in Poland-characteristics of Polish biobanking units at the beginning of BBMRI.pl organization.波兰生物银行的格局——BBMRI.pl 组织成立之初的波兰生物银行单位的特点。
J Transl Med. 2021 Jun 22;19(1):267. doi: 10.1186/s12967-021-02926-y.
7
Consensus-Driven Development of a Terminology for Biobanking, the Duke Experience.基于共识的生物样本库术语开发:杜克大学的经验
Biopreserv Biobank. 2017 Apr;15(2):126-133. doi: 10.1089/bio.2016.0092. Epub 2017 Mar 24.
8
Baobab Laboratory Information Management System: Development of an Open-Source Laboratory Information Management System for Biobanking.猴面包树实验室信息管理系统:用于生物样本库的开源实验室信息管理系统的开发。
Biopreserv Biobank. 2017 Apr;15(2):116-120. doi: 10.1089/bio.2017.0014. Epub 2017 Apr 4.
9
Basic principles of biobanking: from biological samples to precision medicine for patients.生物样本库的基本原则:从生物样本到患者的精准医疗。
Virchows Arch. 2021 Aug;479(2):233-246. doi: 10.1007/s00428-021-03151-0. Epub 2021 Jul 13.
10
Sustainability in Biobanking.生物样本库中的可持续性
Methods Mol Biol. 2019;1897:1-6. doi: 10.1007/978-1-4939-8935-5_1.

引用本文的文献

1
Data Management in Biobanking: Strategies, Challenges, and Future Directions.生物样本库中的数据管理:策略、挑战与未来方向。
BioTech (Basel). 2024 Sep 2;13(3):34. doi: 10.3390/biotech13030034.
2
Data Model for the Comprehensive Management of Biobanks and Its Contribution to Personalized Medicine.生物样本库综合管理的数据模型及其对个性化医疗的贡献。
J Pers Med. 2024 Jun 21;14(7):668. doi: 10.3390/jpm14070668.
3
Need for a Dedicated Ophthalmic Malignancy Clinico-Biological Biobank: The Nice Ocular MAlignancy (NOMA) Biobank.建立专门的眼科恶性肿瘤临床生物学生物样本库的必要性:尼斯眼恶性肿瘤(NOMA)生物样本库

本文引用的文献

1
Supplementation with subspecies EVC001 for mitigation of type 1 diabetes autoimmunity: the GPPAD-SINT1A randomised controlled trial protocol.补充 EVC001 亚株以减轻 1 型糖尿病自身免疫:GPPAD-SINT1A 随机对照试验方案。
BMJ Open. 2021 Nov 9;11(11):e052449. doi: 10.1136/bmjopen-2021-052449.
2
Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol.口服胰岛素治疗用于高遗传风险婴儿的 1 型糖尿病一级预防:GPPAD-POInT(预防自身免疫性糖尿病初级口服胰岛素试验全球平台)研究方案。
BMJ Open. 2019 Jun 28;9(6):e028578. doi: 10.1136/bmjopen-2018-028578.
3
Cancers (Basel). 2023 Apr 19;15(8):2372. doi: 10.3390/cancers15082372.
Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials-GPPAD-02 study design and first results.
为将患 1 型糖尿病风险较高的婴儿纳入原发性预防试验(GPPAD-02 研究)而进行的婴儿鉴定-研究设计和初步结果。
Pediatr Diabetes. 2019 Sep;20(6):720-727. doi: 10.1111/pedi.12870. Epub 2019 Jun 13.